Stratos Wealth Partners, Ltd. Astrazeneca PLC Transaction History

Stratos Wealth Partners, Ltd.

$6.9 Billion
Q4 2024

A detailed history of Stratos Wealth Partners, Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 13,476 shares of AZN stock, worth $990,486. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,476

Previous 14,311 5.83%

Holding current value

$990,486

Previous $1.12 Million 20.9%

% of portfolio

0.01%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$63.2 - $79.58 $52,772 - $66,449	-835 Reduced 5.83%	13,476 $882,000
Q3 2024 Oct 17, 2024	BUY	$76.67 - $87.62 $13,033 - $14,895	170 Added 1.2%	14,311 $1.12 Million
Q2 2024 Jul 24, 2024	SELL	$66.81 - $80.83 $30,331 - $36,696	-454 Reduced 3.11%	14,141 $1.1 Million
Q1 2024 Apr 16, 2024	BUY	$61.03 - $69.57 $61,152 - $69,709	1,002 Added 7.37%	14,595 $988,000
Q4 2023 Jan 24, 2024	SELL	$61.89 - $69.28 $16,153 - $18,082	-261 Reduced 1.88%	13,593 $915,000
Q3 2023 Oct 24, 2023	BUY	$64.85 - $71.7 $56,030 - $61,948	864 Added 6.65%	13,854 $938,000
Q2 2023 Jul 18, 2023	BUY	$69.91 - $75.81 $237,274 - $257,299	3,394 Added 35.37%	12,990 $929,000
Q1 2023 Apr 27, 2023	SELL	$63.15 - $71.6 $242,369 - $274,800	-3,838 Reduced 28.57%	9,596 $666,000
Q4 2022 Jan 19, 2023	SELL	$54.21 - $70.44 $25,858 - $33,599	-477 Reduced 3.43%	13,434 $0
Q3 2022 Oct 24, 2022	SELL	$53.02 - $135.75 $56,784 - $145,388	-1,071 Reduced 7.15%	13,911 $763,000
Q2 2022 Jul 22, 2022	SELL	$59.26 - $71.14 $173,750 - $208,582	-2,932 Reduced 16.37%	14,982 $990,000
Q1 2022 Apr 26, 2022	SELL	$55.72 - $67.12 $10,921 - $13,155	-196 Reduced 1.08%	17,914 $1.19 Million
Q4 2021 Jan 14, 2022	SELL	$54.02 - $63.83 $324,876 - $383,873	-6,014 Reduced 24.93%	18,110 $1.06 Million
Q3 2021 Oct 19, 2021	SELL	$55.56 - $60.79 $34,725 - $37,993	-625 Reduced 2.53%	24,124 $1.45 Million
Q2 2021 Jul 19, 2021	SELL	$48.42 - $60.18 $169,712 - $210,930	-3,505 Reduced 12.41%	24,749 $1.48 Million
Q1 2021 Apr 27, 2021	BUY	$47.16 - $54.44 $48,480 - $55,964	1,028 Added 3.78%	28,254 $1.41 Million
Q4 2020 Jan 29, 2021	BUY	$48.52 - $58.02 $819,308 - $979,725	16,886 Added 163.31%	27,226 $1.36 Million
Q3 2020 Oct 29, 2020	SELL	$53.07 - $61.1 $12,630 - $14,541	-238 Reduced 2.25%	10,340 $567,000
Q2 2020 Jul 28, 2020	BUY	$43.1 - $55.31 $455,222 - $584,184	10,562 Added 66012.5%	10,578 $560,000
Q3 2019 Nov 12, 2019	BUY	$40.12 - $45.47 $641 - $727	16 New	16 $201,000
Q2 2018 Aug 13, 2018	SELL	$34.55 - $37.05 $139,823 - $149,941	-4,047 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$32.97 - $36.63 $10,484 - $11,648	318 Added 8.53%	4,047 $142,000
Q4 2017 Feb 09, 2018	SELL	$32.09 - $34.78 $116,743 - $126,529	-3,638 Reduced 49.38%	3,729 $129,000
Q3 2017 Nov 07, 2017	BUY	$28.96 - $34.0 $213,348 - $250,478	7,367	7,367 $250,000

Others Institutions Holding AZN

# of Institutions

1,366

Shares Held

476M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Account

Stratos Wealth Partners, Ltd. Astrazeneca PLC Transaction History